VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
DINARDO, COURTNEY
One or more keywords matched the following items that are connected to
DINARDO, COURTNEY
Item Type
Name
Concept
Triazines
Academic Article
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Academic Article
Novel Therapeutics in Acute Myeloid Leukemia.
Academic Article
Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation.
Academic Article
Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study.
Academic Article
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.
Academic Article
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia.
Academic Article
Venetoclax-based therapies for acute myeloid leukemia.
Academic Article
How I treat acute myeloid leukemia in the era of new drugs.
Academic Article
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial.
Academic Article
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Academic Article
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.
Academic Article
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia.
Academic Article
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.
Academic Article
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy.
Academic Article
IDH2 mutations in acute myeloid leukemia.
Search Criteria
Triazines